Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 20
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Payment of exercise price or tax liability
|
Direct |
2,045
-4.82%
|
$173,825
$85.38 P/Share
|
|
Aug 15
2024
|
Gary Louis Corona Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,966
+21.35%
|
-
|
|
Aug 02
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
2,887
-2.25%
|
$233,847
$81.51 P/Share
|
|
Aug 02
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct |
3,490
+5.11%
|
-
|
|
Aug 02
2024
|
Matthew R. Walter SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
441
-0.86%
|
$35,721
$81.51 P/Share
|
|
Aug 02
2024
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
684
+2.57%
|
-
|
|
Aug 02
2024
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
5,063
-5.29%
|
$410,103
$81.51 P/Share
|
|
Aug 02
2024
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
5,311
+9.75%
|
-
|
|
Aug 02
2024
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
SELL
Payment of exercise price or tax liability
|
Direct |
9,210
-4.97%
|
$746,010
$81.51 P/Share
|
|
Aug 02
2024
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Exercise of conversion of derivative security
|
Direct |
14,514
+10.43%
|
-
|
|
Aug 02
2024
|
Jennifer M Kirk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
476
-0.82%
|
$38,556
$81.51 P/Share
|
|
Aug 02
2024
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,138
+3.78%
|
-
|
|
Aug 02
2024
|
Michael Marinaro EVP & President, Surgical OU |
SELL
Payment of exercise price or tax liability
|
Direct |
1,410
-1.62%
|
$114,210
$81.51 P/Share
|
|
Aug 02
2024
|
Michael Marinaro EVP & President, Surgical OU |
BUY
Exercise of conversion of derivative security
|
Direct |
1,670
+3.67%
|
-
|
|
Aug 02
2024
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,172
-4.58%
|
$1,471,932
$81.51 P/Share
|
|
Aug 02
2024
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,966
+8.54%
|
-
|
|
Aug 02
2024
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,729
-6.5%
|
$545,049
$81.51 P/Share
|
|
Aug 02
2024
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,132
+11.77%
|
-
|
|
Aug 02
2024
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
3,436
-2.53%
|
$278,316
$81.51 P/Share
|
|
Aug 02
2024
|
Sean Salmon EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
5,462
+7.38%
|
-
|
|
Jul 31
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,406
-2.24%
|
$112,480
$80.32 P/Share
|
|
Jul 29
2024
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,625
+23.23%
|
-
|
|
Jul 29
2024
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
14,375
+18.66%
|
-
|
|
Jul 29
2024
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
14,375
+24.69%
|
-
|
|
Jul 29
2024
|
Michael Marinaro EVP & President, Surgical OU |
BUY
Grant, award, or other acquisition
|
Direct |
13,750
+24.61%
|
-
|
|
Jul 29
2024
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+17.85%
|
-
|
|
Jul 29
2024
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
14,375
+18.56%
|
-
|
|
Jul 29
2024
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,139
+22.58%
|
-
|
|
Jul 29
2024
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Grant, award, or other acquisition
|
Direct |
12,750
+19.49%
|
-
|
|
Jul 18
2024
|
Matthew R. Walter SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
492
+2.72%
|
$30,504
$62.76 P/Share
|
|
Jun 07
2024
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
19,113
-5.94%
|
$1,586,379
$83.79 P/Share
|
|
Jun 07
2024
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,113
+5.4%
|
$1,185,006
$62.76 P/Share
|
|
May 01
2024
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.42%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Kevin E Lofton Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-2.99%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-1.21%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.25%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.42%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.5%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.97%
|
$15,360
$80.89 P/Share
|
|
May 01
2024
|
Lidia Fonseca Director |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-4.21%
|
$12,960
$80.89 P/Share
|
|
May 01
2024
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-2.26%
|
$15,360
$80.89 P/Share
|
|
Apr 29
2024
|
Gregory P Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,821
+50.0%
|
$145,680
$80.86 P/Share
|
|
Apr 29
2024
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+25.21%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+12.01%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+2.73%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+4.49%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+5.33%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+9.86%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Lidia Fonseca Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+36.03%
|
$173,200
$80.86 P/Share
|
|
Apr 29
2024
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,165
+20.3%
|
$173,200
$80.86 P/Share
|